Literature DB >> 28166681

B cells in multiple sclerosis.

Hartmut Wekerle1.   

Abstract

B lymphocytes have essential roles in the autoimmune pathogenesis of multiple sclerosis (MS). They regulate the autoimmune response and participate in the development of the CNS lesions. This review discusses nature and functions of B cells in MS, and retraces the recruitment of brain-autoimmune B cells from the B cell repertoire. Multiple sclerosis is commonly considered as an autoimmune demyelinating disease, where myelin-reactive T cells enter the CNS from outside, and drive the inflammatory changes that ultimately create the degenerative MS plaque. Most therapeutic strategies focus on eliminating or mitigating these pathogenic T cells. Less consideration has been devoted to the role of autoimmune B cells in the autoimmune pathogenesis. Indeed, this role is now supported by a number of convergent lines of evidence, which are briefly outlined in a first part of this overview. A second part describes experimental studies in transgenic mouse models of brain autoimmunity, EAE, which relate to possible functions of autoimmune B cells and to their recruitment from the regular B cell repertoire.

Entities:  

Keywords:  B cell; Multiple sclerosis; autoimmunity; central nervous system; experimental autoimmune encephalomyelitis

Mesh:

Substances:

Year:  2017        PMID: 28166681     DOI: 10.1080/08916934.2017.1281914

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  24 in total

Review 1.  Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis.

Authors:  Hadi Atabati; Esmaeil Yazdanpanah; Hamed Mortazavi; Saeed Gharibian Bajestani; Amir Raoofi; Seyed-Alireza Esmaeili; Azad Khaledi; Ehsan Saburi; Jalil Tavakol Afshari; Thozhukat Sathyapalan; Abbas Shapouri Moghaddam; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Different Susceptibility of T and B Cells to Cladribine Depends On Their Levels of Deoxycytidine Kinase Activity Linked to Activation Status.

Authors:  Federico Carlini; Federico Ivaldi; Francesca Gualandi; Ursula Boschert; Diego Centonze; Giuseppe Matarese; Marco Salvetti; Nicole Kerlero de Rosbo; Antonio Uccelli
Journal:  J Neuroimmune Pharmacol       Date:  2021-04-14       Impact factor: 4.147

3.  Immune-cell crosstalk in multiple sclerosis.

Authors:  Richard M Ransohoff
Journal:  Nature       Date:  2018-11       Impact factor: 49.962

Review 4.  [Cladribine tablets : Oral immunotherapy of relapsing-remitting multiple sclerosis with short yearly treatment periods].

Authors:  S G Meuth; T Ruck; O Aktas; H-P Hartung
Journal:  Nervenarzt       Date:  2018-08       Impact factor: 1.214

Review 5.  Therapeutic potential of curcumin for multiple sclerosis.

Authors:  Munibah Qureshi; Ebtesam A Al-Suhaimi; Fazli Wahid; Omer Shehzad; Adeeb Shehzad
Journal:  Neurol Sci       Date:  2017-10-27       Impact factor: 3.307

6.  The Future of Immunotherapy: A 20-Year Perspective.

Authors:  David C Wraith
Journal:  Front Immunol       Date:  2017-11-28       Impact factor: 7.561

Review 7.  Multiple Sclerosis: Immunopathology and Treatment Update.

Authors:  Narges Dargahi; Maria Katsara; Theodore Tselios; Maria-Eleni Androutsou; Maximilian de Courten; John Matsoukas; Vasso Apostolopoulos
Journal:  Brain Sci       Date:  2017-07-07

8.  Silencing miR-150 Ameliorates Experimental Autoimmune Encephalomyelitis.

Authors:  Zhaolan Hu; Yanhui Cui; Xiaoqing Qiao; Xinwen He; Fang Li; Cong Luo; Shuang Wang; Changqi Li; Ruping Dai
Journal:  Front Neurosci       Date:  2018-07-10       Impact factor: 4.677

9.  Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis.

Authors:  Caterina Veroni; Barbara Serafini; Barbara Rosicarelli; Corrado Fagnani; Francesca Aloisi
Journal:  J Neuroinflammation       Date:  2018-01-16       Impact factor: 8.322

Review 10.  Cross-Talk of the CNS With Immune Cells and Functions in Health and Disease.

Authors:  Agata Matejuk; Arthur A Vandenbark; Halina Offner
Journal:  Front Neurol       Date:  2021-05-31       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.